Tinnitus. Tinnitus
Conditions
Interventions
Intervention 1: Intervention group: They will receive 0.625 mg of conjugated estrogens and 2.5 mg of medroxyprogesterone daily for three months. Intervention 2: Control group: They will receive one pl
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: Female gender Menopause within the last 10 years Having the patient's consent to participate in the study
Exclusion criteria
Exclusion criteria: Having depression History of calcium, vitamin, and magnesium intake two months before intervention Tinnitus caused by medication side effects Suspicion and diagnosis of tumoral lesions Patients with conductive or mixed hearing loss
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the intensity of tinnitus. Timepoint: Before treatment and at the end of the third month of treatment. Method of measurement: With visual analog scale.;Changes in disability scores due to tinnitus. Timepoint: Before treatment and at the end of the third month of treatment. Method of measurement: With the Tinnitus Tinnitus Handicap Inventory (THI).;Loudness and frequency of tinnitus. Timepoint: Before treatment and at the end of the third month of treatment. Method of measurement: Audiometric test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of drug side effects. Timepoint: During treatment. Method of measurement: Questioning the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAbbas Moradi
Hamedan University of Medical Sciences
Outcome results
None listed